Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19473483

Download in:

View as

General Info

PMID
19473483